latest thinking on treating osteoporosis in postmenopausal women
April 2002
Here's the latest thinking on treating osteoporosis in postmenopausal women.
Fosamax and Actonel are widely-used oral bisphosphonates. They increase bone density and prevent fractures by inhibiting bone resorption. But some patients can't take them due to GI side effects.
Zometa (zoledronic acid) is also a bisphosphonate, but it's given IV. It's recently approved for hypercalcemia and bone metastases in cancer patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote